Get the Stockscreener App
3.84
1.05%
0.04
Pre-market:
3.85
0.01
+0.26%
Revance Therapeutics Inc Stock (RVNC) Forecast
The Revance Therapeutics Inc (RVNC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.5065, representing a +147.57% increase from the current price of $3.84. The highest analyst price target is $12.34, and the lowest is $6.6712.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RVNC Price Target
Average 15.66
(+307.87% Upside)
Is Revance Therapeutics Inc (RVNC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.28 | Neutral |
| STOCH(9,6) | 33.14 | Neutral |
| STOCHRSI(14) | 33.45 | Neutral |
| MACD(12,26) | -0.4412 | Sell |
| ADX(14) | 38.09 | Sell |
| William %R | -81.61 | Buy |
| CCI(14) | -57.42 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.939
Sell
|
4.1668
Sell
|
| MA20 |
4.838
Sell
|
4.5536
Sell
|
| MA50 |
5.1889
Sell
|
4.9689
Sell
|
| MA100 |
5.0426
Sell
|
5.0177
Sell
|
| MA200 |
4.6043
Sell
|
5.987
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RVNC could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on RVNC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.28 indicates that RVNC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.14 indicates that RVNC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 33.45 indicates that RVNC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.09 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -57.42 indicates that RVNC is still oversold but not to an extreme extent.
Long-term RVNC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Revance Therapeutics Inc financial reports and earnings history, Revance Therapeutics Inc (RVNC) stock could reach $6.4079 by 2030, $21.91 by 2040 and $13.41 by 2050. See the projected annual prices until 2050 of the Revance Therapeutics Inc stock below:
- Revance Therapeutics Inc (RVNC) is expected to reach an average price of $0.6922 in 2035, with a high prediction of $2.7674 and a low estimate of $0.5198. This indicates an $-81.97% rise from the last recorded price of $3.84.
- Revance Therapeutics Inc (RVNC) stock is projected to chart a bullish course in 2040, with an average price target of $19.91, representing an $418.36% surge from its current level. The forecast ranges from a conservative $17.32 to a sky-high $21.91.
- Our analysts predict Revance Therapeutics Inc (RVNC) to jump 177.89% by 2045, soaring from $4.8011 to an average price of $10.67, potentially reaching $12.25. While $4.8011 is the low estimate, the potential upside is significant.
- Revance Therapeutics Inc (RVNC) stock is expected to climb by 2050, reaching an average of $9.333, a $143.05% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.41 and $11.79, respectively, highlighting the market's uncertainty.
Revance Therapeutics Inc Stock (RVNC) Year by Year Forecast
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2024
Our forecast for RVNC stock price in 2024 now indicates an average price target of $6.9037 with a high forecast of $12.34 and a low forecast of $1.4655. The average prediction reflects an increase of +79.78% from the last recorded price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $8.1848 | $6.6712 | $12.34 | +113.15% |
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2025
Revance Therapeutics Inc Stock (RVNC) is expected to reach an average price of $15.66 in 2025, with a high prediction of $27.40 and a low estimate of $3.9242. This indicates an +307.87% rise from the last recorded price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.6809 | $7.226 | $8.466 | +100.02% |
| February, 2025 | $14.46 | $7.3021 | $15.38 | +276.45% |
| March, 2025 | $14.49 | $14.27 | $20.01 | +277.36% |
| April, 2025 | $6.6216 | $3.9242 | $16.61 | +72.44% |
| May, 2025 | $8.2614 | $4.7278 | $8.979 | +115.14% |
| June, 2025 | $11.66 | $8.5663 | $14.12 | +203.55% |
| July, 2025 | $15.74 | $11.75 | $16.57 | +309.82% |
| August, 2025 | $17.27 | $15.67 | $19.76 | +349.66% |
| September, 2025 | $18.69 | $15.41 | $19.33 | +386.77% |
| October, 2025 | $19.86 | $16.40 | $22.57 | +417.13% |
| November, 2025 | $17.96 | $17.87 | $27.40 | +367.78% |
| December, 2025 | $18.81 | $16.26 | $21.77 | +389.81% |
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2026
The predicted value for Revance Therapeutics Inc (RVNC) in 2026 is set at an average of $21.74. Estimates vary from a peak of $27.59 to a trough of $15.90, indicating an +466.27% surge from the present price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $17.80 | $15.90 | $21.91 | +363.64% |
| February, 2026 | $19.90 | $16.52 | $21.65 | +418.19% |
| March, 2026 | $21.82 | $19.14 | $23.63 | +468.32% |
| April, 2026 | $21.29 | $18.10 | $23.64 | +454.41% |
| May, 2026 | $22.67 | $17.25 | $22.80 | +490.47% |
| June, 2026 | $21.59 | $19.48 | $22.94 | +462.21% |
| July, 2026 | $22.63 | $19.80 | $23.91 | +489.19% |
| August, 2026 | $23.65 | $21.09 | $24.55 | +515.88% |
| September, 2026 | $26.97 | $22.60 | $27.59 | +602.24% |
| October, 2026 | $22.90 | $22.00 | $26.98 | +496.37% |
| November, 2026 | $20.71 | $19.33 | $23.11 | +439.21% |
| December, 2026 | $21.86 | $19.73 | $24.03 | +469.31% |
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Revance Therapeutics Inc (RVNC) is $14.26, with a high forecast of $22.33 and a low forecast of $6.1906. This indicates an +271.40% increase from the last price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.5564 | $7.1264 | $22.33 | +148.87% |
| February, 2027 | $7.9512 | $7.2876 | $9.87 | +107.06% |
| March, 2027 | $10.94 | $6.5837 | $11.19 | +184.83% |
| April, 2027 | $9.7521 | $8.9421 | $12.15 | +153.96% |
| May, 2027 | $7.8369 | $6.2745 | $9.5633 | +104.09% |
| June, 2027 | $9.833 | $6.1906 | $10.27 | +156.07% |
| July, 2027 | $14.17 | $8.1042 | $15.30 | +268.95% |
| August, 2027 | $11.80 | $11.55 | $15.45 | +207.36% |
| September, 2027 | $8.8587 | $6.9187 | $13.07 | +130.69% |
| October, 2027 | $7.8535 | $6.2135 | $9.1749 | +104.52% |
| November, 2027 | $10.38 | $7.9247 | $10.59 | +170.27% |
| December, 2027 | $17.62 | $9.1895 | $18.22 | +358.97% |
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2028
In 2028, Revance Therapeutics Inc (RVNC) is projected to reach an average price of $23.82, with a high projection of $34.05 and a low estimate of $13.59. This indicates an +520.24% rise from the last price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.95 | $14.35 | $17.94 | +341.39% |
| February, 2028 | $22.30 | $15.26 | $24.75 | +480.83% |
| March, 2028 | $17.72 | $17.16 | $26.28 | +361.46% |
| April, 2028 | $18.50 | $14.41 | $19.97 | +381.90% |
| May, 2028 | $15.21 | $14.43 | $19.32 | +296.12% |
| June, 2028 | $27.39 | $13.59 | $27.61 | +613.17% |
| July, 2028 | $28.01 | $26.84 | $31.74 | +629.44% |
| August, 2028 | $24.51 | $24.28 | $32.44 | +538.19% |
| September, 2028 | $29.99 | $23.65 | $29.99 | +681.03% |
| October, 2028 | $30.66 | $25.31 | $30.89 | +698.34% |
| November, 2028 | $27.21 | $26.04 | $34.05 | +608.65% |
| December, 2028 | $21.55 | $20.85 | $28.62 | +461.12% |
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2029
The 2029 price forecast for Revance Therapeutics Inc Stock (RVNC) is $11.05 on average, with a high prediction of $21.61 and a low estimate of $0.4863. This represents an +187.71% increase from the previous price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $19.97 | $18.08 | $21.61 | +420.13% |
| February, 2029 | $14.93 | $13.36 | $19.89 | +288.75% |
| March, 2029 | $13.31 | $11.64 | $15.39 | +246.69% |
| April, 2029 | $5.2377 | $4.7377 | $13.51 | +36.40% |
| May, 2029 | $2.6737 | $2.4837 | $6.5189 | -30.37% |
| June, 2029 | $4.0285 | $2.4449 | $4.3549 | +4.91% |
| July, 2029 | $5.6634 | $3.7397 | $6.0234 | +47.48% |
| August, 2029 | $2.0094 | $2.0094 | $6.6396 | -47.67% |
| September, 2029 | $2.5542 | $2.0006 | $3.083 | -33.48% |
| October, 2029 | $2.0403 | $1.9403 | $4.6666 | -46.87% |
| November, 2029 | $1.0351 | $0.8801 | $2.2215 | -73.04% |
| December, 2029 | $5.10 | $0.4863 | $4.16 | +32.81% |
Revance Therapeutics Inc Stock (RVNC) Price Forecast for 2030
Revance Therapeutics Inc Stock (RVNC) is expected to reach an average price of $6.0859 in 2030, with a high forecast of $12.07 and a low forecast of $0.1031. This signifies an +58.49% surge from the last price of $3.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.6979 | $5.9776 | $6.4079 | +74.43% |
| February, 2030 | $4.7483 | $5.3607 | $5.0355 | +23.65% |
| March, 2030 | $5.0086 | $5.0886 | $4.5186 | +30.43% |
| April, 2030 | $6.499 | $5.4662 | $6.019 | +69.24% |
| May, 2030 | $3.8022 | $3.4993 | $5.9265 | -0.98% |
| June, 2030 | $1.3172 | $1.7422 | $4.2421 | -65.70% |
| July, 2030 | $0.0848 | $0.7652 | $0.6476 | -97.79% |
| August, 2030 | $0.0445 | $0.1973 | $4.1467 | -98.84% |
| September, 2030 | $3.5942 | $0.1031 | $3.6642 | -6.40% |
| October, 2030 | $9.4962 | $3.0366 | $10.51 | +147.30% |
| November, 2030 | $0.3691 | $1.4841 | $12.07 | -90.39% |
| December, 2030 | $1.8345 | $1.3669 | $1.2707 | -52.23% |
0.93%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):